Journal for ImmunoTherapy of Cancer
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
Journal for ImmunoTherapy of Cancer
J IMMUNOTHER CANCER
ISSN / eISSN
2051-1426 / 2051-1426
Aims and Scope
Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.
Subject Area
IMMUNOLOGY
ONCOLOGY
CiteScore
16.80
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics - Pharmacology | Q1 | #10/301 |
| Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine | Q1 | #12/171 |
| Pharmacology, Toxicology and Pharmaceutics - Oncology | Q1 | #26/366 |
| Pharmacology, Toxicology and Pharmaceutics - Cancer Research | Q1 | #20/214 |
| Pharmacology, Toxicology and Pharmaceutics - Immunology and Allergy | Q1 | #20/211 |
| Pharmacology, Toxicology and Pharmaceutics - Immunology | Q1 | #24/217 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| IMMUNOLOGY - SCIE | Q1 |
| ONCOLOGY - SCIE | Q1 |
H-index
36
Country/Area of Publication
UNITED STATES
Publisher
BioMed Central
Year Publication Started
2013
Annual Article Volume
509
Open Access
YES
Contact
BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND, WC1H 9JR
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started